-
-
-
-
-
-
-
U.S. FDA Acknowledges Receipt of Shire's New Drug Application for SHP465 for ADHD
-
-
-
-
-
-
-
Shire (SHPG) Announces Resubmission of Lifitegrast NDA
-
-
-
15,423 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

